Evidence map›Paper›PMID 38415126›Full record

ArticleQuantitative imaging in medicine and surgery2024

The role of

Chaoran Wang, Guanyun Wang, Wei Wang, Ying Kan, Mingyu Zhang, Jigang Yang

Open access · diamondAbstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Utility ofAnnals of nuclear medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chaoran Wang *Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Guanyun Wang *Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Wei WangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Ying KanDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Mingyu ZhangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jigang YangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Beijing Friendship Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-transplant lymphoproliferative disorder (PTLD) is a significant complication after liver transplantation. Research on the diagnostic value of the Fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography ( Methods: This retrospective study collected the Results: In total, 57 eligible patients were enrolled in this study, of whom 40 had PTLD and 17 had non-PTLD lymphadenopathy. Of the metabolic parameters examined in this study, total lesion glycolysis (TLG) had the highest area under the curve (AUC) value [0.757, 95% confidence interval (CI): 0.632-0.883, P=0.002]. The AUCs of the other metabolic parameters were all less than the AUC of TLG, including the maximum standardized uptake value (SUV Conclusions: The

Indexed as

differential diagnosisFluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (18F-FDG PET/CT)liver transplantmetabolic parameterspediatric

Identifiers

PMID38415126
PMCPMC10895102
OpenAlexW4391268443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.